Citadel Advisors has increased its short position in the Danish biotech company Bavarian Nordic to 0.51 percent of the share capital, from 0.45 percent previously. This means the firm has crossed the disclosure threshold and becomes a new publicly disclosed short seller in the company.
Citadel Advisors is a US asset manager focused on alternative investment strategies.
The Danish Financial Supervisory Authority requires positions above 0.1 percent to be reported and short positions above 0.5 percent to be made public.
